Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01614938|
Recruitment Status : Unknown
Verified June 2012 by Guo-Pei Zhu, Fudan University.
Recruitment status was: Active, not recruiting
First Posted : June 8, 2012
Last Update Posted : June 8, 2012
Information provided by (Responsible Party):
Guo-Pei Zhu, Fudan University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||August 2014|
|Estimated Study Completion Date :||August 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Xu T, Liu Y, Dou S, Li F, Guan X, Zhu G. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study. Oral Oncol. 2015 Sep;51(9):875-9. doi: 10.1016/j.oraloncology.2015.06.008. Epub 2015 Jul 7.